In treating atrial fibrillation, a transmural lesion is key to successful ablation because it keeps errant electrical signals from being transmitted. Today there are many sources being used in a.f. catheter ablations. Following several multicentric studies, now we know that a transmural lesion can be obtained using second generation cryoballoons which create a better balance between safety and efficacy.
In treating atrial fibrillation, a transmural lesion is key to successful ablation because it keeps errant electrical signals from being transmitted. Today there are many sources being used in a.f. catheter ablations. Following several multicentric studies, now we know that a transmural lesion can be obtained using second generation cryoballoons which create a better balance between safety and efficacy.
EHRA EUROPACE CARDIOSTIM 2015
Dosing considerations with the second generation Cryoballoon
New procedure may defeat Brugada's Syndrome
Nuova procedura puo' sconfiggere la sindrome di Brugada
Cryoablation procedure in the treatment of atrial fibrillation
La crioablazione nel trattamento della fibrillazione atriale
Arrhythmic patient management systems: best use of hightech
Identifying new targets for new antiarrhythmic drugs
Identificare nuovi bersagli per nuovi farmaci antiaritmici
Reflex syncope: how to improve the benefit of cardiac pacing
Sincope: la selezione del paziente per l'impianto del pacemaker
